• Elucidating how researchers are using menstrual effluent to track fertility, inflammation, and disease.
• Consumer Adoption & Clinical Validation – The path to making menstrual-based diagnostics a mainstream health tool.
• Investment & Industry Growth – The market potential of menstrual-based biomarkers in diagnostics and therapeutics.

Equip teams with AI tools that capture process knowledge and simulate scale-up scenarios, reducing tech transfer timelines and improving first-batch success rates - critical for aligning R&D, MSAT, and manufacturing expectations early

Explore how ML-enabled real-time control systems and continuous process verification improve yield predictability, reduce rework, and enable faster release - offering a direct line of sight to cost savings and product quality gains

• Discussing the financial burden associated with contraception, gaps in coverage, and how this influences retail access.
• Sharing commercial opportunities by making low-cost contraception more available through ecosystem partnerships.
• How can the industry operationalize OTC coverage and distribution of contraception and other women’s health medications.

• Addressing the under-representation of women in cardiovascular studies and how data-driven clinical outcomes are essential for tailored treatments.
• How new technologies, screenings, and wearables are improving early detection and prevention of heart disease in women.
• How partnerships between healthcare providers, pharmaceutical companies, device, and tech companies, can drive better cardiovascular outcomes for women.

• Understanding FDA approval pathways for women's health drugs and devices.
• Addressing regulatory gaps and challenges in clinical trial design and data collection.
• Strategies for working with regulators to accelerate innovation and ensure patient safety.

• Examining the growing uptake in menopause treatments that cater specific stages and symptoms of menopause.
• Ensuring that personalized menopause treatments are accessible to all women, including socio-economic, cultural, and healthcare system barriers.
• Analyzing trends in provider menopause education & support and payer coverage for holistic menopause care.